Many breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and severity vary.
Flagship poaches another pharma R&D leader as GSK’s Lepore heads to ProFound
John Lepore, the former right-hand man for Hal Barron and Tony Wood at GSK, is departing the UK pharma giant to lead a Flagship Pioneering